1. Home
  2. HLX vs PVLA Comparison

HLX vs PVLA Comparison

Compare HLX & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Helix Energy Solutions Group Inc.

HLX

Helix Energy Solutions Group Inc.

HOLD

Current Price

$9.50

Market Cap

1.4B

Sector

Energy

ML Signal

HOLD

Logo Palvella Therapeutics Inc.

PVLA

Palvella Therapeutics Inc.

HOLD

Current Price

$156.70

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLX
PVLA
Founded
1979
2015
Country
United States
United States
Employees
N/A
29
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.7B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
HLX
PVLA
Price
$9.50
$156.70
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
15
Target Price
$11.50
$171.87
AVG Volume (30 Days)
1.7M
276.7K
Earning Date
04-22-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$876,561,000.00
N/A
Revenue This Year
$2.05
N/A
Revenue Next Year
$5.46
$104,350.18
P/E Ratio
N/A
N/A
Revenue Growth
3.60
N/A
52 Week Low
$5.52
$29.59
52 Week High
$10.75
$161.38

Technical Indicators

Market Signals
Indicator
HLX
PVLA
Relative Strength Index (RSI) 57.64 63.83
Support Level $9.43 $106.07
Resistance Level $9.89 $156.28
Average True Range (ATR) 0.25 10.12
MACD 0.12 0.36
Stochastic Oscillator 85.89 80.10

Price Performance

Historical Comparison
HLX
PVLA

About HLX Helix Energy Solutions Group Inc.

Helix Energy Solutions Group Inc is an offshore energy services company. It provides specialty services to the offshore energy industry, with an emphasis on well intervention and robotics operations. Helix provides services in deep water in the Gulf of Mexico, Brazil, the North Sea, Asia Pacific and West Africa regions. It has four segments: Well Intervention, Robotics, Shallow Water Abandonment and Production Facilities. The Well Intervention segment includes vessels and equipment used to perform well intervention services in the Gulf of Mexico, the North Sea and Brazil. It derives the majority of its revenue from the U.S., and it also has its presence in North Sea, Brazil, Asia Pacific, West Africa, and Other.

About PVLA Palvella Therapeutics Inc.

Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company whose vision is to become the rare disease biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no FDA-approved therapies. Its product candidate, QTORIN 3.9% rapamycin anhydrous gel, is currently in clinical development for microcystic lymphatic malformations and cutaneous venous malformations. It operates in single segment.

Share on Social Networks: